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To determine whether Lassa virus was circulating in 
southern Mali, we tested samples from small mammals from 
3 villages, including Soromba, where in 2009 a British citi-
zen probably contracted a lethal Lassa virus infection. We 
report the isolation and genetic characterization of Lassa 
virus from an area previously unknown for Lassa fever.
L
assa fever is an acute viral infection associated with a 
wide spectrum of disease manifestations, which range 
from mild to hemorrhagic fever characterized by multiorgan 
failure (1). The etiologic agent of Lassa fever is Lassa virus 
(LASV, family Arenaviridae, genus Arenavirus), which is 
maintained in its natural rodent reservoir, the multimam-
mate rat (Mastomys natalensis) (1–3). Although M. natalen-
sis rats are ubiquitous in many parts of sub-Saharan Africa, 
infected rodents have only been reported in West African 
countries, most commonly Nigeria, Sierra Leone, and Guin-
ea (3–5). Consequently, cases of Lassa fever mainly occur 
in regions in which the virus is endemic, consisting of those 
3 countries and Liberia, with an annual incidence ranging 
from 300,000 to 500,000 cases and ≈5,000 deaths (6). Se-
rologic evidence of LASV infections has also been reported 
from other West and Central African countries (5,7–9). 
Additionally, LASV has been introduced into Europe and 
North America several times, making Lassa fever one of the 
most prominent imported exotic viral hemorrhagic fevers, 
which strongly affects public health systems (9).
In 2009, Lassa fever was diagnosed postmortem in a 
young man with a 10-day history of fever who had been 
evacuated from Mali to London (10). The patient had no 
travel history to any LASV-endemic region, which sug-
gests that he contracted the infection in Mali, most likely 
while working in the village of Soromba (Figure 1). In this 
report, we provide evidence that LASV is circulating in M. 
natalensis in southern Mali, thereby expanding the geo-
graphic distribution of LASV in West Africa and posing 
a risk to humans in an area previously unknown for Lassa 
fever. The study was carried out in accordance with a pro-
tocol approved by an Institutional Animal Care and Use 
Committee of the US National Institutes of Health. 
The Study
From June 5 through 14, 2009, a total of 103 small 
mammals (trap success rate of 17.6%) were live trapped 
and sampled from 3 villages in Mali (Figure 1; Table): 
N’Tessoni (11°2′0′′N, 5°59′0′′W), Soromba (10°35′0′′N, 
7°9′0′W), and Doneguebougou (12°48′21′′N, 7°59′0′′W). 
Pertinent information was recorded for each animal, and 
ear punch, heart, blood, lung, and liver samples were col-
lected. Mastomys spp. rats were the predominant rodent 
captured (82/103, 79.6%), with all but 4 of these animals 
identiﬁ  ed as M. natalensis rat by cytochrome B sequence 
analysis of DNA isolated from ear punch specimens (11; 
GenBank accession nos. HM130517–HM130519).
Total RNA was extracted from tissue specimens and 
blood by using RNeasy or QIAamp viral RNA kits (QIA-
GEN, Valencia, CA, USA), respectively, and screened 
for the presence of LASV RNA by using a SYBR-green 
based, real-time reverse transcription–PCR assay that 
ampliﬁ  es a 195-bp portion of the small genomic segment 
(primers Gc656s: 5′-ATTGCTCTTGACTCAGGCC-3′ 
and Gc851as: 5′-GTGTCCATGTGAATGTGCCTA-3′; 
TIB Molbiol GBH, Adelphia, NJ, USA). Six infected ro-
dents were identiﬁ  ed, each of which had LASV-positive 
lung, liver, and blood specimens. Positive rodents were 
genetically identiﬁ  ed as M. natalensis, and all were cap-
tured from Soromba, for a village prevalence of 24% (6/25, 
Table). Four (66.7%) of 6 infected rodents were male and 
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Figure 1. Ecozones of Mali and locations where small mammals 
were trapped in June 2009. Inset shows location of Mali in relation 
to countries where Lassa virus is endemic (shaded).  5 (83.3%) of 6 were adult. All 6 infected animals were cap-
tured indoors.
Tissue homogenates were prepared from selected 
LASV-positive animals and passaged twice on subcon-
ﬂ  uent monolayers of Vero E6 cells. After 2 passages, 
no discernible cytopathic effect was observed, although 
LASV RNA was detected by reverse transcription–PCR 
in cells and supernatant. Virus isolation was conﬁ  rmed 
by immunoblot analysis in infected cells and supernatant 
by using a LASV nucleoprotein-speciﬁ  c monoclonal an-
tibody, which detected a 50–55-kDa protein consistent in 
size with the LASV nucleoprotein (12; online Appendix 
Figure, panel A, www.cdc.gov/EID/content/16/7/1123-
appF.htm). Furthermore, electron microscopy performed 
on infected cells showed viral particles consistent in size 
and morphologic features with an arenavirus (online Ap-
pendix Figure, panel B).
An  ≈800-nt fragment of the LASV polymerase 
gene was ampliﬁ  ed from the isolated virus and the tis-
sues of infected rodents by using a pan–Old World are-
navirus assay (13). Additionally, an 873-bp fragment of 
the LASV glycoprotein gene, corresponding to the se-
quence from a British Lassa fever patient (10), was am-
pliﬁ  ed from the same samples by using primers Gc F1 5′-
GCATTTTAATTCAGCCTCAATTAAC-3′ and Gc R1 
5′-ATGGGGCAGATTGTGACATTCTTTC-3′. Ampli-
cons were sequenced (GenBank accession nos. GU573541–
GU573546 and GU573547–GU573552 for polymerase 
and glycoprotein fragments, respectively) and aligned with 
previously described arenavirus sequences by using Clust-
alX version 2.0.10 software (www.clustal.org). Nucleotide 
sequences from the isolated LASV were indistinguishable 
from the sequences generated from the infected rodent 
tissues from which they were derived (data not shown). 
Phylogenetic analysis of the glycoprotein sequences con-
ﬁ  rmed that all rodent-derived LASV sequences belonged 
to the same genetic clade as the sequence of the imported 
Lassa fever case in the United Kingdom. Polymerase frag-
ment sequences conﬁ  rmed that this clade is most closely 
related to the previously described AV strain of LASV that 
originated from the neighboring countries of Côte d’Ivoire, 
Burkina Faso, or Ghana (14; Figure 2).
Conclusions
This study demonstrates that M. natalensis rats in Mali 
carry a genetically unique strain of LASV (proposed name 
Soromba-R). Genetically, Soromba-R is nearly indistin-
guishable from the nucleotide sequence generated from a 
lethal case of Lassa fever imported from Mali to the United 
Kingdom, which supports the epidemiologic data that the 
infection occurred in the village of Soromba in southern 
Mali (10). The Soromba-R strain of LASV is genetically 
closely related to the AV strain, which was isolated from an 
imported lethal Lassa fever case in a patient who contracted 
the infection while traveling in neighboring countries (14). 
Thus, this study provides evidence for an expanded region 
of LASV endemicity in West Africa.
On the basis of Mali’s geographic proximity to coun-
tries where LASV is endemic, it should not be surprising 
that LASV is circulating there. Cases of Lassa fever are di-
agnosed annually in Guinea, and sporadic cases have been 
diagnosed in Burkina Faso and Côte d’Ivoire, all of which 
border Mali (5,14,15). Furthermore, although to date only 1 
laboratory-conﬁ  rmed Lassa fever case has been diagnosed 
from Mali, there is serologic evidence of a LASV infection 
in 1971 in a missionary stationed in Mali (8). Consider-
ing this probable case and the identiﬁ  cation of a geneti-
cally unique strain of LASV in rodents and a human case 
from Mali, it is likely that LASV has been present in Mali 
yet undetected for decades. The nonspeciﬁ  c clinical signs 
and symptoms of a large proportion of LASV infections, 
combined with the unfamiliarity of Malian physicians with 
Lassa fever, suggest that the infection could easily be mis-
diagnosed. Currently, Lassa fever is not considered in the 
differential diagnosis for febrile illness in Mali. This report, 
however, provides evidence of an emerging infectious dis-
ease problem with public health effects; thus, Lassa fever 
diagnostics and surveillance should be implemented at least 
in the southern regions of Mali.
Soromba and the surrounding area may represent an 
enzootic hotspot for LASV-infected rodents. However, a 
greater distribution of LASV in Mali should not be ruled 
out, particularly in the southern regions of the country 
where the climate and geography are similar to conditions 
found in many parts of Guinea and Sierra Leone (Figure 
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Table. Results of investigation of small mammals trapped in 3 villages in Mali, 2009 
Village 
No. total captures 
(trap success, %)* 
No. non–Mastomys 
spp. rat captures 
No. Mastomys spp. rat  
captures (trap success, %) 
No. (%) Lassa-positive 
M. natalensis rats
N’Tessoni 25 (14.9)  8† 17 (10.1)‡  0
Soromba  25 (15.0)  0 25 (15.0)  6 (24) 
Doneguebougou  53 (21.1)  13† 40 (15.9)‡  0
*Trap success is defined as the total number of individual rodents captured divided by the cumulative total of traps set at each location,  multiplied by 
100. 
†Non-Mastomys species captured included 1 Praomys daltoni (Dalton’s mouse), 3 Mus musculoides (Temminck’s mouse), 3 Crocidura olivieri (giant 
shrew), and 1 Arvicanthis niloticus (grass rat) from N’Tessoni and 1 Praomys daltoni, 1 Rattus rattus rat, 1 Arvicanthis niloticus, 3 Crocidura viaria
(savannah path shrew), and 7 Crocidura olivieri from Doneguebougou. 
‡Two Mastomys spp. rodents captured in N’Tessoni and Doneguebougou were identified as M. erythroleucus by cytochrome B sequencing. Lassa Virus, Mali
1). Combined with our ﬁ  ndings that M. natalensis was the 
predominant species of rodent captured in all 3 villages in 
Mali suggests that conditions favor LASV circulation. Fur-
thermore, on the basis of the timing of the peak incidence 
of Lassa fever cases, which typically corresponds with the 
dry season (15), we believe that the proportion of LASV-
infected rodents may have been low at the time of these 
studies and beyond the sensitivity of the limited sampling 
effort conducted here. Future studies need to address these 
concerns as well as determine the geographic distribution 
of LASV-infected rodents in Mali to help focus public 
health preparedness efforts.
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Figure 2. Phylogenetic analysis of Lassa virus conducted on A) a 754-bp fragment of the polymerase gene (large genomic segment nucleo-
tide positions 3427–4180) and B) a 771-bp fragment of the glycoprotein precursor (small genomic segment nucleotide positions 2526–
3296). The fragments were ampliﬁ  ed from infected rodent tissues with sequence analysis accomplished with PHYLIP version 3.69 software 
(http://evolution.genetics.washington.edu/phylip.html) by using the neighbor-joining method with 1,000 replicates of bootstrap. Sequences 
were compared with the following arenavirus sequences (small and large segment GenBank accession nos.): Tacaribe (NC_004293, 
NC_004292), Lujo (NC_012776, NC_012777), Lymphocytic choriomeningitis virus (LCMV, strain Armstrong, AY847350,J04331), Ippy 
(NC_007905, NC_007906), Mobala (NC_007903, NC_007904), Morogoro (NC_013057, NC_013058), Mopeia (NC_006575, NC_006574), 
and Lassa virus strains 803213 (AF803213, AY693640), CSF (AF333969, AY179174), NL (AY179173, AY179172), Josiah (AY628203, 
U63094), Z148 (AY628205, AY628204), Macenta (AY628201, AY628200), and AV (AF246121, AY179171). Small segment analysis also 
included Lassa virus strains LP (AF18185), Weller (AY628206), Nigeria (M36544), the sequence generated from the imported case of 
Lassa fever from Mali (FJ824031), and Junin virus (NC_005081). Bootstrap values >800 are shown. *Whether the AV strain of Lassa 
virus originated from Côte d’Ivoire, Burkina Faso, or Ghana is not clear. Italicized names represent sequences generated as part of these 
studies. Scale bars indicate 5% (A) or 20% (B) nucleotide divergence.Dr Safronetz is a visiting fellow in the Disease Modeling 
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